
P7C3-A20
CAS No. 1235481-90-9
P7C3-A20( —— )
Catalog No. M17211 CAS No. 1235481-90-9
P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 30 | In Stock |
![]() ![]() |
5MG | 47 | In Stock |
![]() ![]() |
10MG | 71 | In Stock |
![]() ![]() |
25MG | 87 | In Stock |
![]() ![]() |
50MG | 152 | In Stock |
![]() ![]() |
100MG | 235 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameP7C3-A20
-
NoteResearch use only, not for human use.
-
Brief DescriptionP7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.
-
DescriptionP7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.
-
In VitroCell Viability Assay Cell Line:PC12 cells Concentration:10?μM, 20 μM, 40?μM, 60 μM, 80?μM, 100 μM Incubation Time:8 hours Result:Alleviated oxygen-glucose deprivation (OGD)-induced cytotoxicity in PC12 cells. Apoptosis Analysis Cell Line:PC12 cells Concentration:40?μM, 60 μM, 80?μM, 100 μM Incubation Time:8 hours Result:Alleviated oxygen-glucose deprivation (OGD)-induced apoptosis in PC12 cells.
-
In VivoAnimal Model:Sprague-Dawley rats (200-250 g) induced hypoxic-ischemic (HI) injury Dosage:5?mg/kg, 10?mg/kg Administration:Intraperitoneal injection; daily; for 7 days Result:Reduced infarct volume; reversed cell loss in the cortex and hippocampus and improved motor function without causing neurotoxicity.
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetSrc
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1235481-90-9
-
Formula Weight506.2
-
Molecular FormulaC22H19Br2FN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL. 197.55 mM; H2O : < 0.1 mg/mL
-
SMILESCOc1cccc(c1)NCC(Cn1c2c(cc(cc2)Br)c2c1ccc(c2)Br)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. De Jesús-Cortés H, et al. Proc Natl Acad Sci U S A. 2012 Oct 16; 109(42):17010-5.
molnova catalog



related products
-
NCGC00262650
NCGC00262650 is an inhibitor of AMA1-RON2 interaction and c-Src tyrosine kinase activity.
-
eCF506
eCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?
-
DGY-06-116
DGY-06-116 is an selective and irreversible covalent inhibitor of Src and FGFR1 with IC50 value of 3nM and 8340 nM, respectively.